Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2015

01-03-2015 | Letter to the Editor

Emergency internal carotid artery stenting with platelet glycoprotein IIbIIIa antagonist coverage in a patient with essential thrombocytosis

Authors: Wing-Yan Au, Man-Fai Law, Edmond S. K. Ma, Ka-Hung Pang, Yiu-Ting Kan

Published in: Annals of Hematology | Issue 3/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Au WY, Fung A, Liu CL, Fan ST, Ma SK, Liang R et al (2006) Serial analysis of JAK2 mutation in a patient who developed essential thrombocythemia after orthotopic liver transplantation. Am J Hematol 81:880–2PubMedCrossRef
2.
Au WY, Liu CL, Lo CM, Fan ST, Ma SK (2004) Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis. J Clin Apheresis 19:192–6PubMedCrossRef
3.
Doesch C, May AE, Toncar-Pflumm G, Anders N, Geisler T, Krober S et al (2007) Acute thrombo-embolic elevated ST infarct in a patient with essential thrombocytosis. Internist (Berl) 48:1282–9CrossRef
4.
Kohl DW, Slavik KJ, Kamath G, Lehr JM, McDonald MJ, Rubio F (1998) High-dose abciximab during coronary angioplasty in a patient with essential thrombocytosis. J Invasive Cardiol 10:173–6PubMed
5.
Michaels AD, Whisenant B, MacGregor JS (1998) Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia. Clin Cardiol 21:134–8PubMedCrossRef
6.
Kornblihtt LI, Cocorullo S, Miranda C, Lylyk P, Heller PG, Molinas FC (2005) Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement. Stroke 36:E71–3PubMedCrossRef
7.
Setacci C, de Donato G, Setacci F, Chisci E, Cappelli A, Pieraccini M et al (2005) Surgical management of acute carotid thrombosis after carotid stenting: a report of three cases. J Vasc Surg 42:993–6PubMedCrossRef
8.
Zahn R, Ischinger T, Hochadel M, Mark B, Zeymer U, Jung J et al (2007) Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Clin Res Cardiol 96:730–7PubMedCrossRef
9.
De Stefano V, Za T, Rossi E, Vannuchhi AM, Ruggeri M, Elli E, GIMEMA Chronic Myeloproliferative Neoplasms Working Party et al (2010) Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. Am J Hematol 85:97–100PubMed
10.
Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, United Kingdom Medical Research Council Primary Thrombocythemia 1 Study et al (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 353:33–45PubMedCrossRef
Metadata
Title
Emergency internal carotid artery stenting with platelet glycoprotein IIbIIIa antagonist coverage in a patient with essential thrombocytosis
Authors
Wing-Yan Au
Man-Fai Law
Edmond S. K. Ma
Ka-Hung Pang
Yiu-Ting Kan
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2168-z

Other articles of this Issue 3/2015

Annals of Hematology 3/2015 Go to the issue

Original Article

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

Original Article

Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia

Letter to the Editor

Preexisting TP53 mutation in therapy-related acute myeloid leukemia

Original Article

Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma

Original Article

Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients

Original Article

Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits